|
|
|
|
Identification of Novel HCV Genotype and Subtypes in
Patients Treated with Sofosbuvir-Based Regimens
|
|
|
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
Charlotte Hedskog1, Neeru Bhardwaj1, Silvia Chang1, Bandita Parhy1, Ross Martin1, Stefan Zeuzem2, Christophe Moreno3, Stephen Shafran4, Sergio Borgia5, Robert H. Hyland1, John McNally1, Hongmei Mo1, Evguenia S. Svarovskaia1
1Gilead Sciences, Inc., Foster City, CA; 2Johann Wolfgang Goethe University Hospital, Frankfurt, Germany; 3CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; 4University of Alberta, Edmonton, Canada; 5William Osler Health System, Brampton, Ontario, Canada
|
|
|
|
|
|
|